rs17421133
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001365276.2(TNXB):c.12170A>T(p.Asn4057Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.3 in 1,610,306 control chromosomes in the GnomAD database, including 78,750 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001365276.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TNXB | NM_001365276.2 | c.12170A>T | p.Asn4057Ile | missense_variant | 40/44 | ENST00000644971.2 | |
TNXB | NM_019105.8 | c.12164A>T | p.Asn4055Ile | missense_variant | 40/44 | ||
TNXB | NM_032470.4 | c.1457A>T | p.Asn486Ile | missense_variant | 9/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TNXB | ENST00000644971.2 | c.12170A>T | p.Asn4057Ile | missense_variant | 40/44 | NM_001365276.2 |
Frequencies
GnomAD3 genomes ? AF: 0.256 AC: 38708AN: 151314Hom.: 6412 Cov.: 23
GnomAD3 exomes AF: 0.320 AC: 79846AN: 249888Hom.: 14563 AF XY: 0.319 AC XY: 43100AN XY: 135308
GnomAD4 exome AF: 0.305 AC: 445066AN: 1458874Hom.: 72328 Cov.: 73 AF XY: 0.306 AC XY: 221805AN XY: 725826
GnomAD4 genome ? AF: 0.256 AC: 38724AN: 151432Hom.: 6422 Cov.: 23 AF XY: 0.261 AC XY: 19311AN XY: 74006
ClinVar
Submissions by phenotype
Ehlers-Danlos syndrome due to tenascin-X deficiency Benign:2
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 10, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Vesicoureteral reflux 8 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 10, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 09, 2018 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 17, 2018 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at